Questions about good clinical practice in the care of people with ADHD, identified through a stakeholder engagement process, included the following:
- How should ADHD be assessed, diagnosed and monitored, and by whom?
- How often should people with ADHD be seen?
- Are health professionals, including psychiatrists, paediatricians, psychologists, GPs, nurses, pharmacists, allied health professionals and educators adequately trained to treat and support individuals with ADHD?
- For which people with ADHD should a transition between services take place between life stages (preschool to school, primary to secondary school, school to adulthood, older adults)?
- Which clinicians should initiate pharmacological therapy, and continue it long term?
- What principles should clinicians follow when discussing decisions to start, adjust, or discontinue pharmacological treatment for people with ADHD?
- Which factors need to be considered when making initial treatment decisions for ADHD?
- How should ADHD symptom severity and clinical profile guide treatment decisions?
These questions have been addressed in part by the underlying principles described here. This clinical practice guideline makes certain assumptions about ADHD, the context in which care is delivered to people with ADHD, and the services and people who deliver it. Therefore, this guideline should be used with consideration of the following principles and assumptions: